Part 314. PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
- SUBPART A [§ 314.1 - § 314.3] - Subpart A—General Provisions
- SUBPART B [§ 314.50 - § 314.90] - Subpart B—Applications
- SUBPART C [§ 314.92 - § 314.99] - Subpart C—Abbreviated Applications
- SUBPART D [§ 314.100 - § 314.170] - Subpart D—FDA Action on Applications and Abbreviated Applications
- SUBPART E [§ 314.200 - § 314.235] - Subpart E—Hearing Procedures for New Drugs
- SUBPART F - Subpart F [Reserved]
- SUBPART G [§ 314.410 - § 314.445] - Subpart G—Miscellaneous Provisions
- SUBPART H [§ 314.500 - § 314.560] - Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses
- SUBPART I [§ 314.600 - § 314.650] - Subpart I—Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible